Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2016, Article ID 1207240, 3 pages
http://dx.doi.org/10.1155/2016/1207240
Case Report

Use of Aldosterone Antagonist to Treat Diarrhea and Hypokalemia of Ogilvie’s Syndrome

Einstein Medical Center, Philadelphia, PA, USA

Received 3 September 2016; Accepted 27 September 2016

Academic Editor: Olga I. Giouleme

Copyright © 2016 Pradhum Ram et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Maloney and H. D. Vargas, “Acute intestinal pseudo-obstruction (Ogilvie's syndrome),” Clinics in Colon and Rectal Surgery, vol. 18, no. 2, pp. 96–101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Ogilvie, “Large-intestine colic due to sympathetic deprivation; A new clinical syndrome,” British Medical Journal, vol. 2, no. 4579, pp. 671–673, 1948. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Sunnoqrot and R. F. Reilly, “Hypokalemia associated with colonic pseudo-obstruction (Ogilvie's Syndrome),” Case Reports in Nephrology and Dialysis, vol. 5, no. 2, pp. 118–123, 2015. View at Publisher · View at Google Scholar
  4. T. Mathialahan, K. A. Maclennan, L. N. Sandle, C. Verbeke, and G. I. Sandle, “Enhanced large intestinal potassium permeability in end-stage renal disease,” Journal of Pathology, vol. 206, no. 1, pp. 46–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Simon, J.-P. Duong, V. Mallet et al., “Over-expression of colonic K+ channels associated with severe potassium secretory diarrhoea after haemorrhagic shock,” Nephrology Dialysis Transplantation, vol. 23, no. 10, pp. 3350–3352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Mulvihill, E. Passaro Jr., H. Debas, and T. Yamada, “Severe diarrhea after colonic pseudo-obstruction: treatment with somatostatin,” The New England Journal of Medicine, vol. 310, no. 7, pp. 467–468, 1984. View at Publisher · View at Google Scholar · View at Scopus
  7. R. L. Guerrant, L. C. Chen, and J. E. Rohde, “Effect of spironolactone on stool electrolyte losses during human cholera,” Gut, vol. 13, no. 3, pp. 197–200, 1972. View at Publisher · View at Google Scholar · View at Scopus